止血剤・組織用シーラント市場：製品タイプ、材料タイプ、用途、エンドユーザー別-2025-2030年の世界予測

止血剤・組織用シーラント市場は、2024年に68億5,000万米ドルと評価され、2025年には76億9,000万米ドル、CAGR 12.36%で成長し、2030年には137億9,000万米ドルに達すると予測されています。

イントロダクション

止血剤と組織シーラントの市場は、医療技術の進歩や臨床現場のシフトに後押しされ、大きな進化を遂げています。近年、これらの重要な手術補助剤の世界市場は、安全で効果的な外科手術に対する需要の増加とともに拡大しています。本レポートでは、技術革新、進化する患者のニーズ、規制の進展がどのように融合して市場を形成し、競合戦略を再定義しているかを探る。多様な臨床現場における製品開発、展開、採用に影響を与える複雑な力学に関する洞察を提供します。手術結果や患者の安全性に対する監視の目が厳しくなる中、製品開発者からエンドユーザーに至るまで、利害関係者は精度、効率、費用対効果の達成に注力しています。この後のディスカッションでは、主要な市場促進要因や、市場拡大に拍車をかけ、協力の新たな道を開き、臨床転帰を改善する戦略的アプローチについて包括的な視点を提供します。読者は、今後のセクションの分析に取り組むことで、技術的躍進と永続的な臨床の伝統の両方によって決定される市場をナビゲートする準備ができます。

止血剤・組織用シーラント市場の変革

最近の業界の変革は、止血材・組織シーラント市場を再定義しています。生体工学に基づく材料や洗練された製造技術などの新たな技術革新により、製品の性能と信頼性が飛躍的に向上しています。病院や診療所における操作手順にも顕著な変化が生じています。新たな規制方針と進化する償還の枠組みにより、製品開発は患者の安全性と品質保証に密接に沿ったものとなっています。画像技術の向上とデジタルツールの外科手術への統合により、医師はこれらの製品をより正確に使用できるようになり、合併症の減少と回復時間の短縮が実現しています。これと並行して、主要サプライヤーと研究機関との戦略的提携が製品革新を加速させ、止血や創傷シーリングにおける過去の限界に対処する画期的な進歩をもたらしています。リアルタイムの転帰をモニターするデータ分析の役割は、製品アプリケーションを微調整するための実用的な洞察を提供し、継続的な改善が臨床上の必要性を満たす環境を育んでいます。このダイナミックな変化の時代には、企業は新たな流通モデルを受け入れ、エビデンスに基づく研究を製品開発のライフサイクルに組み込み、市場統合や規制の進化に直面しても適応し続けることが求められます。

主なセグメンテーションの洞察

市場セグメンテーションを詳細に調べると、製品、素材、用途、エンドユーザーの各カテゴリーにおいて、差別化されたビジネスチャンスがあることがわかる。製品タイプ別に見ると、市場は止血材と組織シーラントの領域に明確に分類されます。一方、組織シーラントはフィブリンシーラントと合成シーラントに二分されます。組織シーラントは基本的にフィブリンシーラントと合成シーラントに二分されます。天然素材そのものは、牛由来とヒト由来に基づいてさらに区別され、合成素材はコラーゲンベースとポリマーベースに分けられます。前者には、低侵襲技術が主流である診断処置や軽度の創傷シーリングが含まれ、後者は心臓血管外科、消化器外科、一般外科に細分化され、それぞれ独自の技術的・規制的課題があります。最後に、エンドユーザーのセグメンテーションは、外来手術センターや診療所から病院まで、それぞれの環境に特有の要件や機会が存在する運営環境によって定義されます。こうしたセグメンテーションの枠組みは、業界が求める広範なイノベーションを犠牲にすることなく、それぞれのニッチ市場の可能性に対応するオーダーメイドの戦略を開拓するための基盤となります。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の罹患率の増加と適切なタイミングでの手術の必要性
    • 患者の間で低侵襲手術の需要が高まっている
    • 外科的介入に対する有利な償還ポリシー
  • 抑制要因
    • 外科用シーラントのアウトライン品質が低く、コストが高い
  • 機会
    • 特定の創傷に対するカスタマイズされた止血および密封ソリューションの開発
    • 環境に優しい止血材およびシーラントソリューションの継続的な革新
  • 課題
    • 止血剤・組織用シーラントの利用に関する厳格な基準
• 市場セグメンテーション分析
  • 製品タイプ：長期保存性と信頼性により合成シーラントの重要性が高まっています
  • 用途：非外科的処置における止血剤および組織シーラントの適用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 止血剤・組織用シーラント市場：製品タイプ別

• 止血剤
  • アクティブ止血剤
  • 流動性止血材
  • 機械式止血鉗子
• 組織シーラント
  • フィブリンシーラント
  • 合成シーラント

第7章 止血剤・組織用シーラント市場：素材タイプ別

• 天然素材
  • 牛由来
  • ヒト由来
• 合成素材
  • コラーゲンベース
  • ポリマーベース

第8章 止血剤・組織用シーラント市場：用途別

• 非外科的処置
  • 診断手順
  • 軽度の創傷閉鎖
• 外科手術
  • 心臓血管外科
  • 消化器外科
  • 一般外科

第9章 止血剤・組織用シーラント市場：エンドユーザー別

• 外来手術センター
• クリニック
• 病院

第10章 南北アメリカの止血剤・組織用シーラント市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の止血剤・組織用シーラント市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの止血剤・組織用シーラント市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Advanced Medical Solutions Group PLC
• Aegis Lifesciences Private Limited.
• B. Braun SE
• Baxter International Inc.
• Becton, Dickinson and Company
• Cardinal Health, Inc.
• CooperSurgical, Inc.
• CryoLife, Inc.
• CSL Behring
• CuraMedical B.V.
• Grifols, S.A.
• Hemostasis, LLC
• Hologic, Inc.
• Integra LifeSciences Corporation
• Johnson & Johnson Services, Inc.
• KAKEN PHARMACEUTICAL CO., LTD.
• KATSAN Katgut Sanayi ve Tic. A.S.
• Medline Industries, LP.
• Medtronic PLC
• Olympus Corporation
• Owens & Minor
• Pfizer, Inc.
• Smith & Nephew PLC
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation
• Thermo Fisher Scientific Inc.
• Vivostat A/S
• Zimmer Biomet

LIST OF FIGURES

• FIGURE 1. HEMOSTATS & TISSUE SEALANTS MARKET MULTI-CURRENCY
• FIGURE 2. HEMOSTATS & TISSUE SEALANTS MARKET MULTI-LANGUAGE
• FIGURE 3. HEMOSTATS & TISSUE SEALANTS MARKET RESEARCH PROCESS
• FIGURE 4. HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 17. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 19. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. HEMOSTATS & TISSUE SEALANTS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 25. HEMOSTATS & TISSUE SEALANTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. HEMOSTATS & TISSUE SEALANTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HEMOSTATS & TISSUE SEALANTS MARKET DYNAMICS
• TABLE 7. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY ACTIVE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY FLOWABLE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MECHANICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC SEALANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY BOVINE-DERIVED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HUMAN-DERIVED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COLLAGEN-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MINOR WOUND SEALING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY GASTROINTESTINAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 57. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 64. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 65. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 66. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 73. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 74. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 75. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 76. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 77. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 79. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 80. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 82. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 84. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 86. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 90. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 93. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 94. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 99. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 100. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 102. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 104. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 108. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 110. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 111. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 113. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 114. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 115. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 116. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 117. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 118. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 119. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 121. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 122. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 124. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 125. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 126. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 127. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 128. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 129. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 131. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 132. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 134. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 135. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 136. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 137. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 138. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 139. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 141. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 142. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 144. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 145. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 146. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 147. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 148. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 149. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 151. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 152. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 153. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 154. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 155. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 156. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 157. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 158. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 159. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 161. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 162. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 164. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 165. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 166. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 167. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 168. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 169. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 171. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 172. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 173. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 174. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 175. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 176. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 177. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 178. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 179. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 181. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 182. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 183. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 184. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 185. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 186. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 187. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 188. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 189. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 191. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 192. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 193. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 194. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 195. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 196. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 197. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 198. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 203. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 204. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 205. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 206. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 207. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 208. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 209. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 211. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 212. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 213. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 214. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 215. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 216. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 217. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 218. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 219. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 221. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 222. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 223. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 224. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 225. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 226. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 227. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 228. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 229. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 231. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 232. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 233. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 234. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 235. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 236. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 237. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 238. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 239. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 240. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 241. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 242. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 243. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 244. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 245. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 246. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 247. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 248. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 249. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 250. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 251. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 252. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 253. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 254. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 255. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 256. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 257. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 258. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 259. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 260. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 261. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 262. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 263. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 264. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 265. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 266. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 267. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 268. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 269. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 270. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 271. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 272. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 273. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 274. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 275. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 276. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 277. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 278. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 279. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 280. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 281. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 282. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 283. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 284. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 285. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 286. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 287. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 288. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 289. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 290. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 291. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 292. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 293. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 294. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 295. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 296. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 297. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 298. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 299. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 300. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 301. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 302. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 303. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 304. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 305. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 306. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 307. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 308. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 309. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 310. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 311. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 312. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 313. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD M

The Hemostats & Tissue Sealants Market was valued at USD 6.85 billion in 2024 and is projected to grow to USD 7.69 billion in 2025, with a CAGR of 12.36%, reaching USD 13.79 billion by 2030.

Introduction

The landscape of hemostats and tissue sealants is witnessing compelling evolution, energized by advances in medical technology and shifts in clinical practices. Over recent years, the global market for these critical surgical adjuncts has grown alongside increasing demand for safe and effective surgical interventions. This report explores how innovation, evolving patient needs, and regulatory developments converge to shape the market and redefine competitive strategies. It provides insights into the intricate dynamics that influence product development, deployment, and adoption across diverse clinical settings. In an era marked by heightened scrutiny on surgical outcomes and patient safety, stakeholders-from product developers to end users-are focused on achieving precision, efficiency, and cost-effectiveness. The discussion that follows delivers a comprehensive perspective on key market drivers and the strategic approaches that are fueling expansion, opening new avenues for collaboration, and offering improved clinical outcomes. Engaging with the analysis in the forthcoming sections, readers are prepared to navigate a market determined by both technological breakthroughs and enduring clinical traditions.

Transformative Shifts in the Landscape

Recent industry transformations have redefined the hemostats and tissue sealants market. Emerging technological innovations, such as bioengineered materials and refined manufacturing techniques, have dramatically increased product performance and reliability. There is a pronounced shift in operational procedures within hospitals and clinics. New regulatory policies and evolving reimbursement frameworks are ensuring that product development is closely aligned with patient safety and quality assurance. Enhanced imaging technologies and the integration of digital tools into surgical settings are enabling practitioners to apply these products more precisely, reducing complications and improving recovery times. In parallel, strategic collaborations between key suppliers and research institutions have accelerated product innovation, offering breakthroughs that address past limitations in hemostasis and wound sealing. The role of data analytics in monitoring real-time outcomes has provided actionable insights for fine-tuning product applications, thereby fostering an environment where continuous improvement meets clinical necessity. This period of dynamic change calls for companies to embrace new distribution models, incorporate evidence-based research into their product development life cycles, and remain adaptive in the face of market consolidation and regulatory evolution.

Key Segmentation Insights

A granular examination of market segmentation reveals differentiated opportunities across product, material, application, and end-user categories. When viewed through the lens of product type, the market is distinctly categorized into the realms of hemostats and tissue sealants. The hemostats segment evidences further division into active, flowable, and mechanical variants, each offering nuanced benefits that address different clinical demands, while tissue sealants are essentially bifurcated into fibrin sealants and synthetic sealants. Diving deeper, material type segmentation highlights a dichotomy between natural and synthetic materials. Natural materials themselves are further differentiated based on their bovine-derived and human-derived origins, contrasted against synthetic counterparts which, in turn, break down into collagen-based and polymer-based formulations. Application-based segmentation offers insights into usage across both non-surgical and surgical procedures; the former encompasses diagnostic procedures and minor wound sealing where minimally invasive techniques are predominant, while the latter is subdivided into cardiovascular surgery, gastrointestinal surgery, and general surgery, each of which poses unique technical and regulatory challenges. Finally, end-user segmentation is defined by operational settings that range from ambulatory surgical centers and clinics to hospitals, each environment presenting distinct requirements and opportunities. These layered segmentation frameworks provide a foundation for developing tailored strategies that address each niche's market potential without sacrificing the broader scope of innovation that the industry demands.

Based on Product Type, market is studied across Hemostats and Tissue Sealants. The Hemostats is further studied across Active Hemostats, Flowable Hemostats, and Mechanical Hemostats. The Tissue Sealants is further studied across Fibrin Sealants and Synthetic Sealants.

Based on Material Type, market is studied across Natural Materials and Synthetic Materials. The Natural Materials is further studied across Bovine-Derived and Human-Derived. The Synthetic Materials is further studied across Collagen-Based and Polymer-Based.

Based on Application, market is studied across Non-Surgical Procedures and Surgical Procedures. The Non-Surgical Procedures is further studied across Diagnostic Procedures and Minor Wound Sealing. The Surgical Procedures is further studied across Cardiovascular Surgery, Gastrointestinal Surgery, and General Surgery.

Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.

Key Regional Insights

Geographical insights into the market further delineate where opportunities and challenges converge. In the Americas, a mature market environment is characterized by advanced healthcare infrastructure, rigorous regulatory frameworks, and high adoption rates of innovative surgical products. The region's focus on enhancing patient safety and improving surgical outcomes has created fertile ground for both established and emerging companies. In contrast, the combined regions of Europe, Middle East & Africa present a mix of mature markets and emerging economies, where regulatory harmonization efforts play a pivotal role in fostering innovation while addressing regional disparities in healthcare access. The Europe sector benefits from strong research and development investments and a supportive policy environment, while the Middle East and Africa are rapidly evolving through government-led healthcare initiatives and regional collaborations. Meanwhile, the Asia-Pacific region is emerging as a high-growth market fueled by increasing healthcare expenditure, expanding medical infrastructure, and an ever-growing patient base. Rapid urbanization and robust economic growth have boosted investments in advanced medical technologies, ensuring that product portfolios in this category are frequently updated to reflect international standards. In this context, understanding regional nuances is essential for stakeholders aiming to position their offerings effectively across diverse regulatory and cultural landscapes.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights

Analysis of leading entities within the hemostats and tissue sealants domain provides an understanding of competitive strategies and market positioning. Leaders such as Abbott Laboratories, Advanced Medical Solutions Group PLC, and Aegis Lifesciences Private Limited have distinguished themselves by focusing on innovative product design and strategic geographic expansion. Iconic entities like B. Braun SE, Baxter International Inc., and Becton, Dickinson and Company harness their substantial R&D investments to continually enhance product portfolios and improve clinical outcomes. Further, companies like Cardinal Health, CooperSurgical, and CryoLife have demonstrated a commitment to integrating advanced technologies with robust clinical data, driving new standards of care. Firms such as CSL Behring and CuraMedical B.V. excel in merging quality with regulatory excellence, while innovators like Grifols and Hemostasis, LLC deliver cutting-edge approaches to patient care that redefine traditional boundaries. Esteemed market players Hologic, Integra LifeSciences Corporation, and Johnson & Johnson Services, Inc. maintain a sharp strategic focus on expanding their global footprint through dedicated investments in key clinical segments. The competitive landscape is also enriched by contributions from multinational corporations such as KAKEN PHARMACEUTICAL CO., LTD., KATSAN Katgut Sanayi ve Tic. A.S., Medline Industries, and Medtronic PLC, each enhancing the sector's diversity. Additional prominent players, including Olympus Corporation, Owens & Minor, Pfizer, Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Thermo Fisher Scientific Inc., Vivostat A/S, and Zimmer Biomet, fortify their market positions by leveraging their extensive global networks and diversified product strategies. The synthesis of these companies' strategies underscores a relentless pursuit of innovation and excellence, setting benchmarks that drive industry-wide progress.

The report delves into recent significant developments in the Hemostats & Tissue Sealants Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Medical Solutions Group PLC, Aegis Lifesciences Private Limited., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., CooperSurgical, Inc., CryoLife, Inc., CSL Behring, CuraMedical B.V., Grifols, S.A., Hemostasis, LLC, Hologic, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KAKEN PHARMACEUTICAL CO., LTD., KATSAN Katgut Sanayi ve Tic. A.S., Medline Industries, LP., Medtronic PLC, Olympus Corporation, Owens & Minor, Pfizer, Inc., Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Thermo Fisher Scientific Inc., Vivostat A/S, and Zimmer Biomet. Actionable Recommendations for Industry Leaders

Industry leaders must pursue a multipronged strategic approach to fully harness the emerging opportunities within the hemostats and tissue sealants market. Firstly, emphasizing research and development is paramount, with a specific focus on next-generation materials and advanced manufacturing processes that can deliver superior performance in clinical settings. Companies are advised to engage more deeply with academic and clinical institutions to validate innovative product concepts through rigorous trials and evidence-based studies. Strategic collaborations and partnerships can further accelerate product development and market penetration, especially in regions where regulatory landscapes and consumer expectations differ markedly. It is equally important to invest in digital transformation initiatives that streamline supply chains and optimize operational efficiency, enabling a quicker time-to-market for novel products. Additionally, market leaders should refine their segmentation strategies, ensuring that products are tailored to meet the specific needs of diverse clinical applications. This means effectively addressing the demands of non-surgical procedures such as diagnostic and minor wound sealing, alongside more complex surgical interventions like cardiovascular, gastrointestinal, and general surgeries. By developing integrated solutions that cater to the needs of both ambulatory surgical centers and hospital environments, companies can offer a comprehensive product portfolio. Finally, it is crucial to remain agile in the face of evolving regulatory frameworks and market dynamics, thereby ensuring sustained competitive advantage and robust growth trajectories over the long term.

Conclusion

The hemostats and tissue sealants market stands at the forefront of a transformative era in medical technology and surgical care. As the industry evolves, companies must adopt innovative strategies that integrate advanced material science, precise clinical applications, and region-specific market dynamics. The insights shared here illuminate a landscape where precise segmentation, proactive regional focus, and strategic consolidation among leading players are driving significant advancements. The fusion of technological innovation and rigorous clinical research is not only redefining product standards but also paving the way for safer, more efficient surgical outcomes. Stakeholders who capitalize on these trends are likely to secure a competitive edge, leveraging the convergence of emerging technologies and proven clinical practices to come out ahead in an increasingly competitive global market. In summary, a forward-thinking approach that prioritizes research, collaborative innovation, and agile market adaptation is essential for sustained success in this evolving arena.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic disorders and need for timely surgeries
    • 5.1.1.2. Rising demand for minimally invasive surgeries among patients
    • 5.1.1.3. Favorable reimbursement policies for surgical interventions
  • 5.1.2. Restraints
    • 5.1.2.1. Low outlining quality and high costs of surgical sealants
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of customized hemostatic and sealing solutions for specific wounds
    • 5.1.3.2. Ongoing innovations in eco-friendly hemostat and sealant solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Strict standards regarding the utilization of hemostats & tissue sealants
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Rising significance of synthetic sealants owing to their prolonged shelf life and reliability
  • 5.2.2. Application: Expanding application of hemostats and tissue sealants among non-surgical procedures
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Hemostats & Tissue Sealants Market, by Product Type

• 6.1. Introduction
• 6.2. Hemostats
  • 6.2.1. Active Hemostats
  • 6.2.2. Flowable Hemostats
  • 6.2.3. Mechanical Hemostats
• 6.3. Tissue Sealants
  • 6.3.1. Fibrin Sealants
  • 6.3.2. Synthetic Sealants

7. Hemostats & Tissue Sealants Market, by Material Type

• 7.1. Introduction
• 7.2. Natural Materials
  • 7.2.1. Bovine-Derived
  • 7.2.2. Human-Derived
• 7.3. Synthetic Materials
  • 7.3.1. Collagen-Based
  • 7.3.2. Polymer-Based

8. Hemostats & Tissue Sealants Market, by Application

• 8.1. Introduction
• 8.2. Non-Surgical Procedures
  • 8.2.1. Diagnostic Procedures
  • 8.2.2. Minor Wound Sealing
• 8.3. Surgical Procedures
  • 8.3.1. Cardiovascular Surgery
  • 8.3.2. Gastrointestinal Surgery
  • 8.3.3. General Surgery

9. Hemostats & Tissue Sealants Market, by End User

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Clinics
• 9.4. Hospitals

10. Americas Hemostats & Tissue Sealants Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Hemostats & Tissue Sealants Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Hemostats & Tissue Sealants Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. FPNV Positioning Matrix, 2024
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Medcura secures USD 4 million funding to innovate life-saving battlefield hemostats
  • 13.3.2. Grifols expands pediatric surgical care with FDA-approved fibrin sealant enhancing hemostasis outcomes
  • 13.3.3. Teleflex expands market reach with Premier, Inc. through competitive hemostasis product agreements
  • 13.3.4. Olympus Launches EndoClot Hemostatic Agents and Submucosal Injection Agent in European Markets
  • 13.3.5. Corza Medical Signs Definitive Agreement to Acquire Takeda's TachoSil Manufacturing Operations
  • 13.3.6. Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat
  • 13.3.7. Team Develops Extracellular Matrix-Based Sticky Sealants For Corneal Tissue Reconstruction
  • 13.3.8. Medcura Receives Breakthrough Device Designation for its LifeGel(TM) Absorbable Surgical Hemostat
  • 13.3.9. Cresilon Closes $25 Million in Series A-4 Financing to Accelerate Global Expansion and Bring Revolutionary Hemostatic Gel to Human Health Market
  • 13.3.10. ZEISS Receives FDA Clearance for MTLawton - A New Generation of Bipolar Forceps for Electrosurgery
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Advanced Medical Solutions Group PLC
• 3. Aegis Lifesciences Private Limited.
• 4. B. Braun SE
• 5. Baxter International Inc.
• 6. Becton, Dickinson and Company
• 7. Cardinal Health, Inc.
• 8. CooperSurgical, Inc.
• 9. CryoLife, Inc.
• 10. CSL Behring
• 11. CuraMedical B.V.
• 12. Grifols, S.A.
• 13. Hemostasis, LLC
• 14. Hologic, Inc.
• 15. Integra LifeSciences Corporation
• 16. Johnson & Johnson Services, Inc.
• 17. KAKEN PHARMACEUTICAL CO., LTD.
• 18. KATSAN Katgut Sanayi ve Tic. A.S.
• 19. Medline Industries, LP.
• 20. Medtronic PLC
• 21. Olympus Corporation
• 22. Owens & Minor
• 23. Pfizer, Inc.
• 24. Smith & Nephew PLC
• 25. Stryker Corporation
• 26. Teleflex Incorporated
• 27. Terumo Corporation
• 28. Thermo Fisher Scientific Inc.
• 29. Vivostat A/S
• 30. Zimmer Biomet